HomeNDC LookupRxCUI directory › RxCUI 204935

Camphor 100 MG/ML Topical Solution — RxCUI 204935

RxNorm drug concept · Semantic clinical drug
RxCUI 204935 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 8 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI204935
Official nameCamphor 100 MG/ML Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascamphor spirit 10 % Topical Solution; camphor 10 % Concentrate for Topical Solution
FDA products mapped7
Package NDCs mapped8
Reported Medicaid activity (SDUD)444 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Camphor 100 MG/ML Topical Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Camphor 100 MG/ML Topical Solution RxCUI 204935

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Camphor 1952
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Camphor Topical Solution 376329
    • Camphor Topical Product 1155416
    • Topical Solution 316986
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Camphor 100 MG/ML 330605

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Camphor 100 MG/ML SCDC · 330605
  • Camphor Topical Solution SCDF · 376329
  • Camphor Topical Product SCDG · 1155416

📦 FDA Products & Package NDCs

7 products · 8 package NDCs
8 package NDCs map to RxCUI 204935 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00395-0467-16 473 mL in 1 BOTTLE, PLASTIC (0395-0467-16) HUMCO Camphor Spirit Humco Holding Group, Inc. 2013-01-01
00395-0467-92 59 mL in 1 BOTTLE, PLASTIC (0395-0467-92) HUMCO Camphor Spirit Humco Holding Group, Inc. 2013-01-01
49348-0148-30 59 mL in 1 BOTTLE, PLASTIC (49348-148-30) Sunmark Camphor Spirit Strategic Sourcing Services LLC 2017-12-12
53943-0467-92 59 mL in 1 BOTTLE, PLASTIC (53943-467-92) DDM Camphor Spirit Discount Drug Mart 2013-01-01
63868-0490-02 473 mL in 1 BOTTLE, PLASTIC (63868-490-02) Quality Choice Camphor Spirit Chain Drug Market Association 2017-12-12
70000-0396-01 59 mL in 1 BOTTLE (70000-0396-1) LEADER Camphor Spirit Cardinal Health, 110 dba Leader 2018-12-17
70677-1201-01 59 mL in 1 BOTTLE, PLASTIC (70677-1201-1) Camphor Spirit Strategic Sourcing Services, LLC 2024-09-14
82645-0920-92 59 mL in 1 BOTTLE, PLASTIC (82645-920-92) Camphor Spirit Pharma Nobis, LLC 2017-12-12
Observed labelers: Humco Holding Group, Inc. (2) · Cardinal Health, 110 dba Leader (1) · Chain Drug Market Association (1) · Discount Drug Mart (1) · Pharma Nobis, LLC (1) · Strategic Sourcing Services LLC (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0469
Range $0.0447–$0.0469 · middle 50% $0.0458–$0.0469 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.